Study of ANNE One-Wellue Device Array Impact on Hospital Staff Vital Sign Checks

What this Trial Is About

This trial examines how a wireless Bluetooth vital sign array device called the ANNE One-Wellue affects the time hospital staff spend obtaining and recording vital signs for inpatients. It is a randomized controlled trial comparing this new device method to the routine vital sign measurement practices on a general medical floor. The study also looks at patient sleep quality, satisfaction, and healthcare provider experience. Participants in the intervention group will wear the ANNE One device array, which includes sensors worn on the chest, finger, and arm, plus an oral temperature probe used by staff. The control group will have vital signs measured using standard methods without the device array. The study collects data on time spent obtaining and documenting vital signs each day for up to three days per patient. During the study, researchers will assess the total time spent on vital sign measurement by staff, survey patients about their sleep quality during the hospital stay and after discharge, and gather feedback from healthcare providers about using the device array. Surveys are conducted at specified intervals, and all participants will be monitored throughout their hospital stay. The study is sponsored by Northwestern University and is expected to complete by July 2026.

Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity